Effect of concomitant use of yokukansan on steady‐state blood concentrations of donepezil and risperidone in real‐world clinical practice
Neuropsychopharmacology Reports · 2024
DOI: 10.1002/npr2.12459 ↗Kurz gefasst
Fachartikel in der Zeitschrift Neuropsychopharmacology Reports, 2024. Verfasst von Junji Saruwatari und 19 weiteren Autor:innen. Beteiligte Einrichtung: Division of Pharmacology and Therapeutics, Graduate School of Pharmaceutical Sciences, Kumamoto University, Kumamoto, Japan. Hauptthemen laut MEDLINE: Risperidone, Donepezil, Drugs, Chinese Herbal, Schizophrenia. Die Arbeit nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Tsumura & Co..
Abstract (Originalsprache)
Aim
Yokukansan is one of the most frequently used herbal medicines that can improve the behavioral and psychological symptoms of dementia. In this exploratory study, we investigated whether yokukansan affects the steady‐state blood concentrations of donepezil, risperidone, and the major metabolites of both drugs in a real‐world clinical setting.
Methods
A non‐randomized, open‐label, single‐arm study examining drug–drug interactions was conducted. Fifteen dementia patients taking donepezil for at least 4 weeks and eight schizophrenia patients taking risperidone for at least 2 weeks were orally administered 2.5 g of yokukansan three times a day before or between meals, and blood samples were collected before and 8 weeks after starting co‐treatment with yokukansan. Plasma concentrations of donepezil, risperidone, and each metabolite were measured using high‐performance liquid chromatography–tandem mass spectrometry and compared before and after the 8‐week administration of yokukansan.
Results
The plasma concentrations of donepezil and its metabolites (6‐ O ‐desmethyl‐donepezil, 5‐ O ‐desmethyl‐donepezil, and donepezil‐ N ‐oxide), risperidone, and its metabolite paliperidone did not differ before and after the 8‐week treatment with yokukansan.
Conclusions
The findings of this study show that the concomitant use of yokukansan may have little clinical impact on the steady‐state blood levels of donepezil and risperidone in patients with dementia or schizophrenia.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Pharmacology and Therapeutics, Graduate School of Pharmaceutical Sciences, Kumamoto University, Kumamoto, Japan.
- Department of Pharmacy, Kumamoto University Hospital, Kumamoto, Japan.
- Kumamoto Seimei Hospital, Kumamoto, Japan.
- Department of Clinical Pharmaceutical Sciences, Graduate School of Pharmaceutical Sciences, Kumamoto University, Kumamoto, Japan.
- Department of Psychiatry, School of Medicine, Dokkyo Medical University, Tochigi, Japan.
ORCID-Profile: Junji Saruwatari, Tsukasa Murata, Kazutaka Oda, Hirofumi Jono, Norio Yasui-Furukori
Förderung
- Tsumura & Co.
Zitieren
APA
Saruwatari, J., Kaneko, T., Murata, T., Narise, H., Kugimoto, S., Nishimura, E., Tetsuka, N., Ando, M., Oi, M., Ota, M., Hamada, N., Kaneda, K., Furusho, S., Sakamoto, M., Kajiwara-Morita, A., Oda, K., Oniki, K., Ueda, K., Jono, H., & Yasui-Furukori, N. (2024). Effect of concomitant use of yokukansan on steady‐state blood concentrations of donepezil and risperidone in real‐world clinical practice. Neuropsychopharmacology Reports. https://doi.org/10.1002/npr2.12459
Vancouver
Saruwatari J, Kaneko T, Murata T, Narise H, Kugimoto S, Nishimura E, et al. Effect of concomitant use of yokukansan on steady‐state blood concentrations of donepezil and risperidone in real‐world clinical practice. Neuropsychopharmacology Reports. 2024. doi:10.1002/npr2.12459
BibTeX
@article{Saruwatari2024,
author = {Saruwatari, Junji and Kaneko, Tetsuya and Murata, Tsukasa and Narise, Haruka and Kugimoto, Sawa and Nishimura, Eri and Tetsuka, Natsuki and Ando, Misaki and Oi, Momo and Ota, Masako and Hamada, Nayumi and Kaneda, Keiichiro and Furusho, Shiro and Sakamoto, Masakatsu and Kajiwara-Morita, Ayami and Oda, Kazutaka and Oniki, Kentaro and Ueda, Keishi and Jono, Hirofumi and Yasui-Furukori, Norio},
title = {Effect of concomitant use of yokukansan on steady‐state blood concentrations of donepezil and risperidone in real‐world clinical practice},
journal = {Neuropsychopharmacology Reports},
year = {2024},
doi = {10.1002/npr2.12459}
}
EUVIMED